Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Xiang Chao Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6287-3128; OpenAlex author ID A5000529473. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 2 papers

Papers 5

  1. Deubiquitination of FBP1 by USP7 blocks FBP1-DNMT1 interaction and decreases the sensitivity of pancreatic cancer cells to PARP inhibitors. Co-author DOI 10.1002/1878-0261.13149↗
  2. FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression. First author DOI 10.1038/s41388-021-02140-6↗
  3. MIB1 upregulates IQGAP1 and promotes pancreatic cancer progression by inducing ST7 degradation. First author DOI 10.1002/1878-0261.12955↗
  4. MAL2 interacts with IQGAP1 to promote pancreatic cancer progression by increasing ERK1/2 phosphorylation. Co-author DOI 10.1016/j.bbrc.2021.02.146↗
  5. MIB1 Upregulates IQGAP1 and Promotes Pancreatic Cancer Progression by inducing ST7 Degradation Last author DOI 10.21203/rs.3.rs-76668/v1↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xin Jin · 4 shared papers, 2020–2022 · strength 0.74
  2. Feng Guo · 2 shared papers, 2022 · strength 0.40
  3. Heshui Wu · 2 shared papers, 2022 · strength 0.40
  4. Tao Liu · 2 shared papers, 2021 · strength 0.36
  5. Bin Zhang · 2 shared papers, 2020–2021 · strength 0.35
  6. Bin Zhang · 1 shared paper, 2021 · strength 0.17
  7. Tao Liu · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.